Medical/Pharmaceuticals
Earendil Labs Announces First Cohort Dosed in Phase I Study of Novel Biparatopic Antibody Targeting Thymic Stromal Lymphopoietin (TSLP)
WILMINGTON, Del., May 18, 2026 /PRNewswire/ -- Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, today announced the successful completion of cohort 1 dosing in a phase I clinical trial for a novel biparatopic antibody targeting Thymic...
2026-05-18 19:00
4471
Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease
* Congenital adrenal hyperplasia (CAH) and Cushing's disease (CD) are rare disorders characterized by excess adrenocorticotropic hormone (ACTH) produced in the brain1,2 * Current treatments are limited by suboptimal disease control and treatment-related complications3,4 * Asedebart (Lu AG13...
2026-05-18 17:10
3447
PolyU collaborates with global scholars and experts to promote modern healthcare and wellness
Close to 100 participants experience Taichi and Qigong HONG KONG, May 18, 2026 /PRNewswire/ -- The Research Centre for Chinese Medicine Innovation (RCMI) of The Hong Kong Polytechnic University (PolyU) hosted the "Symposium on Martial Arts: Bridging Art and Science" and two "Health Cultivation W...
2026-05-18 14:53
3763
Johnson & Johnson Launches 'Gut Tunnel' Experience in Singapore to Highlight the Importance of Endoscopic Remission in IBD
New data presented at Digestive Disease Week 2026 reinforces endoscopic remission as being associated with long-term patient outcomes,[1],[2] yet more than 60% of people with IBD have not heard of this key treatment goal.[3],[4] Anchoring World IBD Day, the interactive Gut Tunnel installation...
2026-05-18 10:00
3655
Harbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate
Hu-mAtrIx™-Enabled Next-Generation ACVR2A/2B- Targeting Antibody Demonstrates Potential to Become a Best-in-Class Therapy for Obesity CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, May 17, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical compan...
2026-05-18 08:03
3939
WuXi AppTec Recognized as a Top-Performing Company on 2026 Dow Jones Best-in-Class World Index
SHANGHAI, May 17, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has been selected for the 2026 Dow Jones Best-in-Class World Index (DJ BIC World Index, formerly Dow Jones Sustainability World Index), whic...
2026-05-18 08:00
2923
LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma
SEOUL, South Korea, May 17, 2026 /PRNewswire/ -- LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company developing one-of-a-kind PD-1/VEGFR2 dual-paratopic antibodies, reinforcing a growing strategic partn...
2026-05-18 08:00
2475
Eyes that photosynthesise: NUS scientists plant a cure for dry eye disease
A nanosized extract of the plant thylakoid grana — the molecular engine behind photosynthesis — is transplanted into the eye's corneal cells, producing a key protective molecule when exposed to ambient light, opening a new front against dry eye disease SINGAPORE, May 15, 2026 /PRNewswire/ -- Wha...
2026-05-16 11:14
8908
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board
* RB042 Phase 1 trial advances into multiple ascending dose study cohorts, demonstrating safety and tolerabilityto date. * Dr. Coulie brings more than 25 years of international biopharma leadership and deep expertise in pulmonary disease to the Atisama Board of Directors. MELBOURNE, Australia...
2026-05-15 22:25
8971
Malaysia Healthcare Week Myanmar 2026 Opens in Yangon with Leading Hospitals Showcasing Specialised Care for Myanmar Patients
YANGON, Myanmar and KUALA LUMPUR, Malaysia, May 15, 2026 /PRNewswire/ -- Malaysia Healthcare Week Yangon 2026 is officially launched today at Park Royal Yangon, bringing together leading Malaysian hospitals to connect directly with Myanmar patients, healthcare professionals, and industry partners...
2026-05-15 22:04
8384
Racura Oncology Announces Positive Safety Review Committee Recommendation in ongoing CPACS Clinical Trial
Safety Review Committee (SRC) gives Racura Oncology a recommendation to continue the Cardioprotection and Anticancer Synergy (CPACS) study in advanced solid tumor patients SYDNEY, May 15, 2026 /PRNewswire/ -- Racura Oncology, an Australian Phase 3 stage clinical biopharmaceutical company, today ...
2026-05-15 19:06
4617
Phase II Data from a Randomized Double-Blind Trial of Ligufalimab (Anti-CD47) Combination Therapy in Frontline AML Published at EHA 2026
HONG KONG, May 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind, placebo-controlled Phase II trial (AK117-206) of ligufalimab (AK117) will be presented as an oral presentation at the 2026 European ...
2026-05-15 15:43
4911
Ozelle Wins German Innovation Award Gold for Advancing the Fourth Generation of Hematology Analysis
BERLIN, May 15, 2026 /PRNewswire/ -- Ozelle
2026-05-15 14:00
3870
Herbalgy Trophy & "Goal-Getter Giveaway" - A Triumphant Return
Spend HK$180 Unlocks Your Shot at Over HK$1M in Match Tickets – 1,000 Tickets to Chelsea FC vs. Juventus at Kai Tak Buy More, Enter More HONG KONG, May 15, 2026 /PRNewswire/ -- Football fans can now experience the thrill of Chelsea FC vs Juventus live — no trip to Europe required. Pain managemen...
2026-05-15 09:00
3292
SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of 'SNB-101'
SEONGNAM, South Korea, May 14, 2026 /PRNewswire/ -- SN BioScience Inc., a clinical-stage biotechnology company based in South Korea, announced today that it has initiated the first patient dosing in its global Phase 1b/2 clinical trial evaluating SNB-101 (API: SN-38), a nanoparticle anticancer ag...
2026-05-15 07:03
3722
NeuroEndocrine Cancer Australia unveils new website and digital lifeline
NeuroEndocrine Cancer Australia (NECA) has launched a fully updated digital platform designed to improve how the 31,000 Australians affected by neuroendocrine cancer (NETs) access support, information, and specialist care. SYDNEY, May 15, 2026 /PRNewswire/ -- The new website introduces a persona...
2026-05-15 07:00
2781
POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results
GUANGZHOU, China, May 14, 2026 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced its financial results for the fiscal year ended December 31, 2025. Mr. Zhenyang Shi, Chairman a...
2026-05-15 04:30
6774
DeepQure Reports Encouraging Clinical Data from World's First Extravascular RDN System at AUA 2026
WASHINGTON, May 14, 2026 /PRNewswire/ -- DeepQure, a clinical-stage medical device company, announced the completion of its featured presentation at the American Urological Association (AUA) Innovation Nexus Forum, held during the AUA Annual Meeting. DeepQure was selected to present the clinical ...
2026-05-15 02:30
3305
Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA
Clearance Recognises CellDx-Tissue's Dual-Analyte DNA and RNA Workflow Across 517 Cancer-Associated Genes, with ALK, RET and ROS1 Fusion Calls on RNA-Level Evidence NASHIK, India, May 14, 2026 /PRNewswire/ -- Datar Cancer Genetics (DCG), a global precision oncology company, today announced that ...
2026-05-14 23:58
4019
CHEPLAPHARM to Accelerate Global Supply Chain Digitalization with TraceLink MINT
The German pharmaceutical company unifies its digital partner network, laying the foundation for AI-driven supply chain orchestration BOSTON, May 14, 2026 /PRNewswire/ -- TraceLink, the world's largest Agentic Business Network, today announced that the German-based but globally active CHEPLAPHAR...
2026-05-14 22:00
3750
Week's Top Stories
Most Reposted
Asia Pacific Travellers Seek Familiarity, Practicality, Flexibility Amid Shifting Global Dynamics: Visa Report
[Picked up by 326 media titles]
2026-06-16 10:00
Visa and Mintoak Join Forces to Bring Merchant SaaS Capabilities to Acquirers Across Asia Pacific
[Picked up by 312 media titles]
2026-06-17 11:00NOVVA Group acquires 120 MWp Philippines solar project, anchoring its AI-era power platform in Southeast Asia
[Picked up by 298 media titles]
2026-06-19 11:12
MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform
[Picked up by 297 media titles]
2026-06-18 22:01
Affinidi and CardInfoLink Put the Missing Trust Layer for AI Agents into Production
[Picked up by 297 media titles]
2026-06-19 09:00
Most Read
Asia Pacific Travellers Seek Familiarity, Practicality, Flexibility Amid Shifting Global Dynamics: Visa Report
2026-06-16 10:00
6037
Riding the Momentum of APEC's China Year: Telling China's Story Visits Hanyang University, Engages Korean Youth on the Future of Asia-Pacific Cooperation
2026-06-13 07:00
6008
Angel Yeast Releases 2025 Sustainability Report as Company Marks 40th Anniversary
2026-06-13 09:00
5631
Anime "KAGURABACHI" Unveils Chihiro Rokuhira Character Visual & Character Trailer
2026-06-13 09:14
5424
